Proactive Telemedicine to Improve Healthcare Access and Prevention in Rural Primary Care (PTM)

Condition(s) studied

Investigational drug(s) / intervention(s)

Telemedicine Brief Behavioural Lifestyle Intervention: Participants received proactive digital contact via phone or e-consultation. They underwent a brief behavioural intervention addressing modifiable lifestyle factors such as smoking, alcohol consumption, physical activity, and diet. Additionally, access to the rural primary healthcare system will also be measured.

Face to face Brief Behavioural Lifestyle Intervention: Participants attend in-person visits where they undergo a brief behavioural intervention addressing modifiable lifestyle factors (smoking, alcohol, physical activity, diet). Additionally, access to the rural primary healthcare system is also measured.

Study summary

The study evaluates whether Proactive Telemedicine (PTM) can improve healthcare access for individuals who have not contacted their primary care team for at least one year, compared with face-to-face visits. PTM consists of brief, remote behavioral interventions addressing modifiable risk factors such as tobacco use, alcohol consumption (AUDIT-C: Alcohol Use Disorders Identification Test - Consumption), physical activity (IPAQ: International Physical Activity Questionnaire), and Mediterranean diet adherence (PREDIMED: Prevención con Dieta Mediterránea). PTM follows national preventive protocols including PAPPS (Programa de Actividades Preventivas y de Promoción de la Salud) and uses validated tools such as EuroQol-5D-5L (EQ-5D-5L) to measure healthcare accessibility and quality-of-life outcomes. This randomized non-inferiority trial aims to determine whether PTM is as effective and safe as traditional in-person consultations.

Eligibility

Primary outcome measure(s)

• Access to Primary Healthcare — 12-month post-intervention
  Proportion of participants who initiate any contact with primary care during the 12-month post-intervention observation period. Unit of Measure: Proportion (%)
• Health-Related Quality of Life, EuroQol-5D-5L (EQ-5D-5L) — Baseline, 4 months, 8 months
  Change in quality-of-life score measured using the EuroQol-5D-5L instrument. Unit of Measure: Index score (0-1)

Trial sites (1)

More Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina trials in Spain

Other trials for the same condition